Support our Foundation of Myology project
1722 news items
Cipaglucosidase alfa and miglustat in Pompe disease: two-year data
On 22/05/2024
Cipaglucosidase alfa, or Pombiliti®, is a recombinant enzyme being tested in Pompe disease in combination with miglustat (Opfolda®). The combination of the two drug candidates…
ERN EURO-NMD webinar, Prof. Dr. Annemieke Aartsma-Rus (The Netherlands)
On 22/05/2024
Genetic therapies and therapy developments for muscular dystrophies (DMD, LGMD) Wednesday 29 May 2024 – 16:00 – 17:00 Paris time Prof. Dr. Annemieke Aartsma-Rus (Leiden…
Results of a phase I gene therapy trial in giant axon neuropathy
On 21/05/2024
The dose escalation trial evaluated the effects of a single intrathecal injection of four escalating doses of scAAV9/JeT-GAN in 14 patients over the age of…
The importance of developing strategies to manage altered facial expression in FSH
On 21/05/2024
Facial impairment is present in 75% of people with facioscapulohumeral muscular dystrophy (FSHD), and represents a significant psychosocial burden for a third. Given this distress,…
Real-life follow-up of 29 Pompe disease patients treated with Nexviadyme
On 17/05/2024
Using the French Pompe disease registry, data from 29 patients treated with Nexviadyme after loss of efficacy with Myozyme were analyzed. After at least one…
Ultrasound versus MRI for FSHD
On 16/05/2024
A comparison five years apart of ultrasound and MRI scans of five leg muscles from 20 people with facioscapulohumeral muscular dystrophy (FSHD), aged between 35…
Identification of numerous variants on genes involved in mitochondrial diseases in peripheral neuropathies without genetic diagnosis
On 16/05/2024
British researchers have re-examined the genomic analyses of 2,087 people registered on the Genome-Phenome Analysis Platform (GPAP) with possible peripheral neuropathy. They looked for variants…
SNUPN joins the list of genes involved in muscular dystrophies
On 14/05/2024
Two independent international studies, published and also presented at Myology 2024, have reported the involvement of the SNUPN gene in a new form of muscular…
Can a simple blood count predict a myasthenic crisis?
On 13/05/2024
According to a retrospective study conducted in Germany on 15 patients who had suffered a total of 21 myasthenic attacks and 43 patients who had…
A large Iranian cohort of patients with COL-Q deficiency
On 07/05/2024
Iranian clinicians report on a large cohort of 26 patients followed for an average of nine years and in whom the diagnosis of congenital myasthenic…
A look back at Myology 2024
On 06/05/2024
More than 1,100 myology specialists and nearly 90 speakers came together at Myology 2024, the international scientific congress dedicated to muscle science and medicine. Organised by…
Mutations in the SRPK3 gene only lead to skeletal muscle myopathy in combination with a mutation in the TTN gene
On 06/05/2024
An international collaboration describes a cohort of 33 patients with slowly progressive myopathy, beginning in childhood and associated with co-segregation of SRPK3 and TTN variants.…
New techniques improve the diagnostic yield of high-throughput sequencing in neuromuscular diseases
On 03/05/2024
Australian geneticists report on their experience in using more sophisticated high-throughput sequencing techniques (NGS for next-generation sequencing) or transcriptomic studies in the context of a…
Dermatomyositis, polymyositis and the inner ear
On 03/05/2024
In Taiwan, an analysis of reimbursement data for 1,622 patients suffering from polymyositis or dermatomyositis and 8,109 people free of these diseases showed : a…
Whole genome sequencing facilitates genetic diagnosis in CMT
On 03/05/2024
With more than 130 genes involved, the genetic diagnosis of Charcot-Marie-Tooth (CMT) disease and associated neuropathies is a complex process which is not always conclusive.…
Two new genes in Charcot-Marie-Tooth disease
On 02/05/2024
The gene for a seventh aminoacyl-tRNA synthetase has just been implicated in axonal dominant Charcot-Marie-Tooth disease (CMT) thanks to whole exome sequencing of three unrelated…
Adult mitochondrial myopathy: very slowly progressive muscular damage of the limbs, often associated with multisystem damage and high mortality
On 02/05/2024
A retrospective study at the Mayo Clinic in Rochester (Minnesota, USA) was based on 94 cases of mitochondrial myopathy diagnosed in adulthood and followed up…
A new tool for assessing swallowing disorders in young children with SMA
On 30/04/2024
German clinicians were interested in the swallowing disorders present in young patients with SMN1-related proximal spinal muscular atrophy (SMA), treated or untreated, and relatively unexplored…
Virtual reality tele-rehabilitation is feasible and effective in DMD and BMD
On 30/04/2024
Spanish researchers have investigated the usefulness of virtual reality in the remote rehabilitation of 12 walking children aged between 5 and 15 suffering from Duchenne…
A harness to support the mobility of young SMA patients
On 29/04/2024
US physiotherapists have tested a support harness linked to pulleys and a metal frame to facilitate the child’s movements in the three planes of space…
